Coadministration of kla peptide with HPRP-A1 to enhance anticancer activity

The apoptosis-inducing peptide kla (KLAKLAK)(2) possesses the ability to disrupt mitochondrial membranes and induce cancer cell apoptosis, but this peptide has a poor eukaryotic cell-penetrating potential. Thus, it requires the assistance of other peptides for effective translocation at micromolar c...

Descripción completa

Detalles Bibliográficos
Autores principales: Hao, Wenjing, Hu, Cuihua, Huang, Yibing, Chen, Yuxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6839859/
https://www.ncbi.nlm.nih.gov/pubmed/31703065
http://dx.doi.org/10.1371/journal.pone.0223738

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6839859/
https://www.ncbi.nlm.nih.gov/pubmed/31703065
http://dx.doi.org/10.1371/journal.pone.0223738

Ejemplares similares